Revolution Medicines Inc


Market Cap$6.56B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revolution Medicines IncRevolution Medicines Inc-13.50%-28%-0.1

Target Price by Analysts

20.6% upsideRevolution Medicines Target Price DetailsTarget Price

Current Fair Value

87% downside

Overvalued by 87% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.56 Billion
Enterprise Value$4.94 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-3.71
Outstanding Shares164,986,227
Avg 30 Day Volume1,165,189


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-13.54
Price to Sales-
Price to Book Ratio3.77
Enterprise Value to Revenue1082.14
Enterprise Value to EBIT-8.94
Enterprise Value to Net Income-11
Total Debt to Enterprise0.02
Debt to Equity0.05

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Revolution Medicines Inc

CEO: Mark Goldsmith